eMedicine World Medical Library

Excerpt from Epidural Hematoma


Synonyms, Key Words, and Related Terms: EDH, head injury, blunt trauma, hemorrhage, extradural hemorrhage, blood between the skull and dura mater, epidural hematoma

Please click here to view the full topic text: Epidural Hematoma

Background

Epidural hematoma (EDH) is a traumatic accumulation of blood between the inner table of the skull and the stripped-off dural membrane. The inciting event often is a focused blow to the head, such as that produced by a hammer or baseball bat. In 85-95% of patients, this type of trauma results in an overlying fracture of the skull. Blood vessels in close proximity to the fracture are the sources of the hemorrhage in the formation of an EDH. Because the underlying brain has usually been minimally injured, prognosis is excellent if treated aggressively. Outcome from surgical decompression and repair is related directly to patient's preoperative neurologic condition.

Pathophysiology

Approximately 70-80% of EDHs are located in the temporoparietal region where skull fractures cross the path of the middle meningeal artery or its dural branches. Frontal and occipital EDHs each constitute about 10%, with the latter occasionally extending above and below the tentorium. Association of hematoma and skull fracture is less common in young children because of calvarial plasticity.

EDHs are usually arterial in origin but result from venous bleeding in one third of patients. Occasionally, torn venous sinuses cause EDH, particularly in the parietal-occipital region or posterior fossa. These injuries tend to be smaller and associated with a more benign course. Usually, venous EDHs only form with a depressed skull fracture, which strips the dura from the bone and, thus, creates a space for blood to accumulate. In certain patients, especially those with delayed presentations, venous EDHs are treated nonsurgically.

Expanding high-volume EDHs can produce a midline shift and subfalcine herniation of the brain. Compressed cerebral tissue can impinge on the third cranial nerve, resulting in ipsilateral pupillary dilation and contralateral hemiparesis or extensor motor response.

EDHs are usually stable, attaining maximum size within minutes of injury; however, Borovich demonstrated progression of EDH in 9% of patients during the first 24 hours1. Rebleeding or continuous oozing presumably causes this progression. An EDH can occasionally run a more chronic course and is detected only days after injury.

Frequency

United States

EDH occurs in 1-2% of all head trauma cases and in about 10% of patients who present with traumatic coma.

Mortality/Morbidity

  • Reported mortality rates range from 5-43%.
  • Higher rates are associated with the following:
    • Advanced age
    • Intradural lesions
    • Temporal location
    • Increased hematoma volume
    • Rapid clinical progression
    • Pupillary abnormalities
    • Increased intracranial pressure (ICP)
    • Lower Glasgow coma scale (GCS)
  • Mortality rates are essentially nil for patients not in coma preoperatively and approximately 10% for obtunded patients and 20% for patients in deep coma.

Age

  • Patients younger than 5 years and older than 55 years have an increased mortality rate.
  • Patients younger than 20 years account for 60% of EDHs.
  • EDH is uncommon in elderly patients because the dura is strongly adhered to the inner table of the skull. In case series of EDH, fewer than 10% of patients are older than 50 years.

Please click here to view the full topic text: Epidural Hematoma

About Us | Privacy | Code of Ethics | Terms of Use | Contact Us | Advertising | Institutional Subscribers
Labelled with ICRA © 1996-2006 by WebMD.
All Rights Reserved.

Medicine is a constantly changing science and not all therapies are clearly established. New research changes drug and treatment therapies daily. The authors, editors, and publisher of this journal have used their best efforts to provide information that is up-to-date and accurate and is generally accepted within medical standards at the time of publication. However, as medical science is constantly changing and human error is always possible, the authors, editors, and publisher or any other party involved with the publication of this article do not warrant the information in this article is accurate or complete, nor are they responsible for omissions or errors in the article or for the results of using this information. The reader should confirm the information in this article from other sources prior to use. In particular, all drug doses, indications, and contraindications should be confirmed in the package insert. FULL DISCLAIMER